Mirjam C. Boelens
Papers
1
Total Citations
86
H-Index
1
About
Mirjam C. Boelens is a leading figure in translational cancer genomics, whose work is reshaping how we diagnose and treat malignancies. Her research centers on the clinical implementation of whole genome sequencing (WGS) as a comprehensive, all-in-one diagnostic tool. In her landmark 2021 study, "Clinical Validation of Whole Genome Sequencing for Cancer Diagnostics," which has garnered 86 citations, Boelens demonstrated that WGS using fresh-frozen tumor tissue and matched blood samples can serve as the most complete genetic test for cancer patients. This work directly addresses the growing need to screen multiple biomarkers from increasingly small biopsies, offering a powerful alternative to fragmented testing. By validating WGS for routine diagnostics, she has paved the way for more efficient, cost-effective, and holistic tumor profiling. Her contributions are critical in an era where precision oncology demands a single, all-inclusive test to guide therapy decisions, making her a key architect of the future of cancer diagnostics.
Research Focus
Key Achievements
Top Papers
- 1Clinical Validation of Whole Genome Sequencing for Cancer Diagnostics86 citations · 2021